not tagged
not tagged
['multiple myeloma', 'car t']
in patients with multiple myeloma receiving car t therapy, bone marrow mrd negativity was found to be a prognostic factor for survival and response regardless of cellularity and free light chain normalization at 1 month. #asco22 
CGTLive™ delivers quality and relevant information to healthcare professionals on cell, gene, regenerative, and engineered medicines to ultimately improve care.